Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

immunitoAI Raises $6.1M in Series A to Scale AI-Driven Antibody Development Led by Ashish Kacholia.

PRIVATENov 26, 2025•10 months ago

Amount Raised

$6.1 Million

Round Type

Series A

BengaluruBiotechnologyArtificial Intelligence

Investors

A Group Of AngelsJj FamilyLvxJito Incubation & Innovation FoundationAnicut CapitalPi VenturesAc Ventures3one4 CapitalAshish Kacholia

Description

Bengaluru-based immunitoAI has secured $6.1 million in a Series A funding round to enhance its AI-led antibody therapeutics pipeline. The round was led by Ashish Kacholia, who contributed approximately $3 million. The new funding will support the company's efforts in developing proprietary antibodies as part of its intellectual property portfolio. This funding follows earlier seed and bridge funding of about $1.8 million.

Company Information

Company

immunitoAI

Location

Bengaluru, Karnataka, India

About

immunitoAI is a Bengaluru-based biotech startup that develops antibody therapeutics using generative AI models. Founded in 2020, the company aims to accelerate the creation of IP-backed antibodies without traditional biological sources, compressing development timelines significantly. Their technology focuses on therapeutic solutions for conditions such as cancer and infectious diseases. The startup is currently in the pre-revenue stage and targets pharmaceutical companies as its primary customers.

Don't miss immunitoAI's next move

Get an email the moment immunitoAI raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
1 contact
Predictive Intelligence
Strategic

ML-powered predictions for immunitoAI's next move

See what Strategic adds

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

immunitoAI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.